Luis
Montuenga Badía
Catedrático de Universidad
Yale School of Medicine
New Haven, Estados UnidosPublicaciones en colaboración con investigadores/as de Yale School of Medicine (8)
2024
-
Protein Biomarkers in Lung Cancer Screening: Technical Considerations and Feasibility Assessment
Archivos de Bronconeumologia
2023
-
Cancer Cell-Intrinsic Alterations Associated with an Immunosuppressive Tumor Microenvironment and Resistance to Immunotherapy in Lung Cancer
Cancers, Vol. 15, Núm. 12
-
PTEN Loss Confers Resistance to Anti–PD-1 Therapy in Non–Small Cell Lung Cancer by Increasing Tumor Infiltration of Regulatory T Cells
Cancer Research, Vol. 83, Núm. 15, pp. 2513-2526
2022
-
Spatially resolved proteomic profiling identifies tumor cell CD44 as a biomarker associated with sensitivity to PD-1 axis blockade in advanced non-small-cell lung cancer
Journal for immunotherapy of cancer, Vol. 10, Núm. 8
-
The International Association for the Study of Lung Cancer Thymic Epithelial Tumor Staging Project: Unresolved Issues to be Addressed for the Next Ninth Edition of the TNM Classification of Malignant Tumors
Journal of Thoracic Oncology, Vol. 17, Núm. 6, pp. 838-851
-
YES1 Is a Druggable Oncogenic Target in SCLC
Journal of Thoracic Oncology, Vol. 17, Núm. 12, pp. 1387-1403
2017
-
Impaired HLA class I antigen processing and presentation as a mechanism of acquired resistance to immune checkpoint inhibitors in lung cancer
Cancer Discovery, Vol. 7, Núm. 12, pp. 1420-1435
-
Strategies to design clinical studies to identify predictive biomarkers in cancer research
Cancer Treatment Reviews, Vol. 53, pp. 79-97